Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin®)

Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin®)

Abstract One of the most preferable characteristics for a COVID-19 vaccine candidate is the ability to reduce transmission and infection of SARS-CoV-2, in addition to disease prevention. Unlike intramuscular vaccines, intranasal COVID-19 vaccines may offer this by generating mucosal immunity. In thi...

Full description

Bibliographic Details
Main Authors: Chandramani Singh, Savita Verma, Prabhakar Reddy, Michael S. Diamond, David T. Curiel, Chintan Patel, Manish Kumar Jain, Sagar Vivek Redkar, Amit Suresh Bhate, Vivek Gundappa, Rambabu Konatham, Leelabati Toppo, Aniket Chandrakant Joshi, Jitendra Singh Kushwaha, Ajit Pratap Singh, Shilpa Bawankule, Raches Ella, Sai Prasad, Brunda Ganneru, Siddharth Reddy Chiteti, Sreenivas Kataram, Krishna Mohan Vadrevu
Format: Article
Language:English
Published: Nature Portfolio 2023-08-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-023-00717-8

Internet

https://doi.org/10.1038/s41541-023-00717-8

Similar Items